Your browser is no longer supported. Please, upgrade your browser.
Settings
GALE Galena Biopharma, Inc. daily Stock Chart
GALE [NASD]
Galena Biopharma, Inc.
Index- P/E- EPS (ttm)-2.32 Insider Own0.10% Shs Outstand32.13M Perf Week-16.32%
Market Cap20.70M Forward P/E- EPS next Y-1.75 Insider Trans-98.66% Shs Float32.13M Perf Month-63.80%
Income-20.00M PEG- EPS next Q-0.69 Inst Own9.10% Short Float6.68% Perf Quarter-83.52%
Sales- P/S- EPS this Y18.20% Inst Trans21.94% Short Ratio0.95 Perf Half Y-92.84%
Book/sh2.29 P/B0.28 EPS next Y32.40% ROA-51.10% Target Price6.00 Perf Year-96.16%
Cash/sh0.76 P/C0.84 EPS next 5Y- ROE-214.90% 52W Range0.64 - 49.80 Perf YTD-66.79%
Dividend- P/FCF- EPS past 5Y17.90% ROI- 52W High-98.71% Beta2.08
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low0.67% ATR0.15
Employees22 Current Ratio1.00 Sales Q/Q- Oper. Margin- RSI (14)24.57 Volatility6.41% 12.84%
OptionableYes Debt/Eq0.99 EPS Q/Q47.10% Profit Margin- Rel Volume0.79 Prev Close0.65
ShortableYes LT Debt/Eq0.00 EarningsMar 09 AMC Payout- Avg Volume2.25M Price0.64
Recom3.00 SMA20-43.26% SMA50-61.06% SMA200-94.08% Volume1,761,247 Change-0.88%
Feb-06-17Downgrade FBR & Co. Outperform → Mkt Perform $11 → $4
Feb-02-17Downgrade Maxim Group Buy → Hold
Dec-02-16Reiterated Maxim Group Buy $1 → $4
Aug-10-16Reiterated Maxim Group Buy $2 → $1
Jul-22-16Reiterated FBR Capital Outperform $5 → $2
Jul-11-16Reiterated Maxim Group Buy $4 → $2
Jun-29-16Downgrade Raymond James Outperform → Mkt Perform
Dec-22-15Reiterated Maxim Group Buy $7 → $4
Dec-08-15Upgrade Cantor Fitzgerald Sell → Hold
Nov-12-15Upgrade Oppenheimer Perform → Outperform $4
Nov-10-15Reiterated ROTH Capital Buy $8 → $6
Sep-09-15Initiated Raymond James Outperform
Mar-09-15Reiterated Needham Buy $7 → $4
Nov-20-14Reiterated MLV & Co Buy $3 → $5
Aug-22-14Reiterated MLV & Co Buy $5 → $3.50
Aug-12-14Reiterated Needham Buy $9 → $7
Feb-03-14Reiterated Noble Financial Buy $4 → $6
Jan-21-14Reiterated Maxim Group Buy $9 → $11
Jan-08-14Reiterated Maxim Group Buy $6 → $9
Nov-26-13Initiated Oppenheimer Outperform $6
Feb-23-17 04:59PM  How to Dig Deep for Value in These Exuberant Markets
02:00PM  Value Investors Have to Go Deeper
12:06PM  SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Galena Biopharma Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
10:25AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Galena Biopharma, Inc. (GALE) and Lead Plaintiff Deadline: April 14, 2017 Accesswire
Feb-22-17 07:19PM  IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Galena Biopharma Inc., and Encourages Investors with Losses to Contact the Firm Business Wire -9.72%
12:44PM  Investor Alert: Kaplan Fox Announces Investigation Of Galena Biopharma Inc. PR Newswire
Feb-21-17 04:25PM  GALENA BIOPHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibi
04:10PM  Galena Biopharma Board of Directors Appoints Stephen F. Ghiglieri as Interim Chief Executive Officer GlobeNewswire
Feb-20-17 06:14PM  INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Galena Biopharma Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
04:17PM  SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Galena Biopharma Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
03:29PM  GALE FRAUD NOTICE: Rosen Law Firm Reminds Galena Biopharma, Inc. Investors of Important Deadline in Class Action GALE Business Wire
Feb-16-17 02:09PM  The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Galena Biopharma, Inc. Investors and Encourages Investors to Contact the Firm Business Wire
10:10AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Galena Biopharma, Inc. (GALE) & Lead Plaintiff Deadline: April 14, 2017 GlobeNewswire
Feb-15-17 09:05PM  INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Galena Biopharma Inc. and Encourages Investors with Losses to Contact the Firm Business Wire
08:54PM  CORRECTING and REPLACING Glancy Prongay & Murray LLP Files Securities Class Action Lawsuit Against Galena Biopharma, Inc. Business Wire
07:35PM  SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Galena Biopharma, Inc. (GALE) To Contact Brower Piven Before The Lead Plaintiff Deadlin GlobeNewswire
01:11PM  INVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit against Galena Biopharma Inc. and Encourages Investors with Losses to Contact the Firm Business Wire
Feb-14-17 06:27PM  Robbins Arroyo LLP: Galena Biopharma, Inc. (GALE) Misled Shareholders According to a Recently Filed Class Action Business Wire
06:16PM  SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of Galena Biopharma Inc., and Encourages Investors with Losses to Contact the Firm Business Wire
Feb-13-17 04:30PM  Galena Biopharma Announces Closing of Public Offering of Common Stock and Warrants GlobeNewswire +5.41%
12:43PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Galena Biopharma, Inc. (GALE) & Lead Plaintiff Deadline: April 14, 2017 PR Newswire
12:11PM  INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Galena Biopharma, Inc. Investors Business Wire
10:10AM  EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Galena Biopharma, Inc. Business Wire
Feb-10-17 05:49PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Galena Biopharma, Inc. - GALE PR Newswire -9.76%
05:09PM  Pawar Law Group Announces Investigation of Securities Claims Against Galena Biopharma, Inc. - GALE Accesswire
04:57PM  GALENA BIOPHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statem
04:04PM  Biostage, Fossil Group Tumble into Fridays 52-Week Low Club
01:03PM  IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of Galena Biopharma Inc. and Encourages Investors to Contact the Firm Business Wire
12:48PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Galena Biopharma, Inc. (GALE) PR Newswire
12:14PM  EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Galena Biopharma, Inc. GALE Business Wire
Feb-09-17 05:06PM  SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Galena Biopharma Inc. and Advises Investors with Losses to Contact the Firm Business Wire
03:40PM  Glancy Prongay & Murray LLP Commences Investigation on Behalf of Galena Biopharma, Inc. Investors Business Wire
10:15AM  Galena Drops on Discounted $17M Stock Offering at Investopedia
Feb-08-17 04:08PM  Gilead Sciences, Fitbit Plunge into Wednesdays 52-Week Low Club -40.71%
11:35AM  Wednesdays Biggest Biopharma Movers
09:01AM  Galena Biopharma's stock plunges toward record low after stock offering at MarketWatch
08:30AM  Galena Biopharma Announces Pricing of Public Offering of Common Stock and Warrants GlobeNewswire
Feb-07-17 04:10PM  Galena Biopharma Announces Proposed Public Offering of Common Stock and Warrants GlobeNewswire
04:02PM  GALENA BIOPHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Princip
01:00PM  Galena's Breast Cancer Drug NeuVax Was Deemed Safe at Investopedia
Feb-06-17 11:42AM  Why Galena Biopharma Stock Is Soaring Today at Motley Fool +17.50%
07:30AM  Galena Biopharma stock surges 21% after independent group says breast cancer drug has no safety concerns at MarketWatch
07:05AM  Galena Biopharma Reports Positive Outcome from the Data Safety Monitoring Board on the Two NeuVax (nelipepimut-S) Clinical Trials in Combination with Trastuzumab GlobeNewswire
06:28AM  Galena Biopharma downgraded by FBR & Co.
Feb-02-17 08:37AM  Biopharma CEO exits as pain drug marketing probe deepens at bizjournals.com -12.50%
Feb-01-17 03:18PM  Galena CEO Axed Amid Justice Dept Investigation at Investopedia -22.42%
Jan-31-17 06:16PM  Galena Sacks CEO Amid Escalating Criminal Probe Into Fentanyl Drug Marketing
05:00PM  Galena Biopharma Announces the Resignation of its President and Chief Executive Officer and the Evaluation of Strategic Alternatives GlobeNewswire
Jan-25-17 09:45AM  Biotech Industry a Focus in 2017: Latest Reports on Marinus Pharmaceuticals and Galena Biopharma Accesswire
Jan-09-17 04:04PM  DryShips, Stage Stores Plunge into Mondays 52-Week Low Club
07:29AM  GALENA BIOPHARMA, INC. Files SEC form 8-K, Other Events
Jan-05-17 07:05AM  Galena Biopharma to Provide Corporate and Clinical Update and 2017 Outlook During Presentation at Biotech Showcase 2017 GlobeNewswire
Dec-29-16 01:30PM  Galena Biopharma Pipeline Developments Third Quarter 2016 Results and Outlook Accesswire -13.87%
10:08AM  Galena Biopharma Reveals Regulatory Pathway for GALE-401
Dec-28-16 03:43PM  Galena Rises on FDA Approval +21.43%
09:04AM  Galena Biopharma shares jump 26% after news that drug will enter late-stage trial at MarketWatch
07:05AM  Galena Biopharma Confirms Regulatory Pathway for GALE-401 (Anagrelide Controlled Release) GlobeNewswire
Dec-22-16 05:31PM  GALENA BIOPHARMA, INC. Files SEC form 8-K, Other Events -6.25%
11:52AM  Galena Biopharma Stock Has Fallen 93% in 2016 -- Could It Get Any Worse? at Motley Fool
Dec-16-16 10:07PM  Does aTyr Pharma Inc (LIFE) Stack Up Against Its Peers? at Insider Monkey
Dec-14-16 01:18PM  Is Galena Biopharma Inc (GALE) a Good Stock to Buy? at Insider Monkey -5.71%
07:05AM  Galena Biopharma Announces the Phase 2 Clinical Trial of NeuVax (nelipepimut-S) in Ductal Carcinoma in Situ (DCIS) is Open for Enrollment and Screening Patients GlobeNewswire
Dec-12-16 07:05AM  Galena Biopharma Presented Two Posters at the San Antonio Breast Cancer Symposium GlobeNewswire -13.28%
Dec-05-16 02:39PM  Why You Should (and Shouldn't) Buy Galena Biopharma, Inc. at Motley Fool
08:30AM  Galena Biopharma Inc. Presentation Now Available for On-Demand Viewing PR Newswire
08:30AM  Galena Biopharma Inc. Presentation Now Available for On-Demand Viewing CNW Group
Dec-02-16 08:07AM  New Strong Buy Stocks for December 2nd
Dec-01-16 04:39PM  GALENA BIOPHARMA, INC. Files SEC form 8-K, Other Events -10.16%
Nov-30-16 01:31PM  Galena Biopharma to Present Two Posters at the San Antonio Breast Cancer Symposium GlobeNewswire
Nov-29-16 09:30AM  Zacks.com featured highlights: Edgewell Personal Care, Cambrex, Humana, Research Frontiers and Galena Biopharma -7.96%
Nov-25-16 09:01AM  Why BioScrip (BIOS) Could Be Positioned for a Slump
Nov-23-16 04:44PM  Galena Biopharma, Inc. in 3 Charts at Motley Fool
08:30AM  Public Company Executives to Present Online to Investors on December 1 PR Newswire
08:30AM  Public Company Executives to Present Online to Investors on December 1 CNW Group
Nov-22-16 08:30AM  Galena Biopharma Inc. to Webcast, Live, at VirtualInvestorConferences.com December 1 PR Newswire -9.21%
08:30AM  Galena Biopharma Inc. to Webcast, Live, at VirtualInvestorConferences.com December 1 CNW Group
Nov-18-16 08:50AM  New Strong Buy Stocks for November 18th +6.55%
Nov-17-16 01:04PM  GALENA BIOPHARMA, INC. Financials
Nov-16-16 08:52AM  New Strong Buy Stocks for November 16th
Nov-15-16 03:48PM  Biotech Movers And Shakers: Corbus Pharmaceuticals Holdings Inc (CRBP) And Galena Biopharma Inc (GALE) at Insider Monkey
Nov-14-16 07:05AM  Galena Biopharma Presents GALE-301/GALE-302 Phase 1b Data at the Society for Immunotherapy of Cancer Conference 2016 GlobeNewswire -15.71%
04:50AM  Galena Declares 1-for-20 Reverse Split (GALE) at Investopedia
Nov-11-16 09:30AM  Galena Biopharma 3Q Loss $6.9M or 3c/Share (GALE) at Investopedia
Nov-09-16 06:19PM  Galena Biopharma reports 3Q loss +5.56%
04:52PM  GALENA BIOPHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, F
04:10PM  Galena Biopharma Reports Third Quarter 2016 Financial Results and Provides a Corporate Update GlobeNewswire
07:07AM  Q3 2016 Galena Biopharma Inc Earnings Release - After Market Close
Nov-03-16 04:31PM  GALENA BIOPHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers -5.26%
07:05AM  Galena Biopharma Appoints Stephen F. Ghiglieri as Executive Vice President and Chief Financial Officer GlobeNewswire
Nov-02-16 03:13PM  Biotech Movers This Week: Galena Biopharma Inc (GALE) And Oculus Innovative Sciences, Inc. (OCLS) at Insider Monkey
Oct-31-16 04:33PM  GALENA BIOPHARMA, INC. Files SEC form 8-K, Material Modification to Rights of Security Holders -8.00%
04:30PM  Galena Biopharma Announces Reverse Stock Split GlobeNewswire
11:08AM  Research Reports on Biotech Equities -- Mast Therapeutics, Array BioPharma, Galena Biopharma, and Clovis Oncology PR Newswire
Oct-26-16 05:18PM  GALENA BIOPHARMA, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -6.90%
09:30AM  Zacks.com featured highlights: Galena Biopharma, Check Point Software Technologies, Sequans Communications S.A., CubeSmart and Great Panther Silver
07:05AM  Galena Biopharma to Report Third Quarter 2016 Financial Results and Provide a Corporate Update on Wednesday, November 9, 2016 GlobeNewswire
Oct-25-16 06:41AM  5 Top-Ranked Stocks with Rising P/E for Blowout Gains
Oct-20-16 07:05AM  Galena Biopharma Presents GALE-301/GALE-302 Phase 1b Data at the American College of Surgeons Clinical Congress 2016 GlobeNewswire +14.81%
Oct-10-16 07:05AM  Galena Biopharma to Present NeuVax (nelipepimut-S) plus Trastuzumab Interim Safety Data at the European Society for Medical Oncology (ESMO) 2016 Congress GlobeNewswire
Oct-06-16 05:28PM  GALENA BIOPHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhib
Galena Biopharma, Inc., a biopharmaceutical company, focuses on developing and commercializing oncology therapeutics that address major unmet medical needs. The company's lead product candidate, NeuVax (nelipepimut-S), is in Phase III clinical trials for the prevention of recurrence in early- stage and node-positive breast cancer with low to intermediate human epidermal growth factor receptor (HER2) expression; Phase IIb clinical trials in combination with Herceptin for HER2 1+/2+ node-positive and high-risk node-negative breast cancer treatment; and Phase II clinical trials in combination with trastuzumab for node positive and negative HER2 IHC 3+ patients. It also develops GALE-301 (folate binding protein), which is in Phase IIa clinical trials for the prevention of recurrence in patients with ovarian and endometrial cancers; GALE-302, a version of the E39 peptide that is in Phase 1b clinical trial for investigating a novel vaccination series; and GALE-401 (anagrelide controlled release), which is in a Phase II clinical trial for the treatment of patients with myeloproliferative neoplasms to lower elevated platelet levels. Galena Biopharma, Inc. has strategic development and commercialization partnership with Dr. Reddy's Laboratories Ltd. for NeuVax in breast and gastric cancers. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Galena Biopharma, Inc. in September 2011. Galena Biopharma, Inc. was founded in 2003 and is based in San Ramon, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hudson Bay Capital Management 10% OwnerFeb 08Sale0.842,363,4411,985,2902,036,559Feb 10 06:16 PM
Dunlap RyanFormer Chief Financial OfficerJun 01Option Exercise1.79126,875227,394145,577Jun 07 06:36 PM
Dunlap RyanFormer Chief Financial OfficerJun 01Sale2.18126,875276,58818,702Jun 07 06:36 PM